Tang Sze Jing, Luo Shufang, Ho Jia Xin Jessie, Ly Phuong Thao, Goh Eling, Roca Xavier
School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.
School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.
J Biol Chem. 2016 Jul 1;291(27):14311-14323. doi: 10.1074/jbc.M115.710350. Epub 2016 May 12.
Here we present a detailed analysis of the alternative splicing regulation of human CD46, which generates different isoforms with distinct functions. CD46 is a ubiquitous membrane protein that protects host cells from complement and plays other roles in immunity, autophagy, and cell adhesion. CD46 deficiency causes an autoimmune disorder, and this protein is also involved in pathogen infection and cancer. Before this study, the mechanisms of CD46 alternative splicing remained unexplored even though dysregulation of this process has been associated with autoimmune diseases. We proved that the 5' splice sites of CD46 cassette exons 7 and 8 encoding extracellular domains are defined by noncanonical mechanisms of base pairing to U1 small nuclear RNA. Next we characterized the regulation of CD46 cassette exon 13, whose inclusion or skipping generates different cytoplasmic tails with distinct functions. Using splicing minigenes, we identified multiple exonic and intronic splicing enhancers and silencers that regulate exon 13 inclusion via trans-acting splicing factors like PTBP1 and TIAL1. Interestingly, a common splicing activator such as SRSF1 appears to repress CD46 exon 13 inclusion. We also report that expression of CD46 mRNA isoforms is further regulated by non-sense-mediated mRNA decay and transcription speed. Finally, we successfully manipulated CD46 exon 13 inclusion using antisense oligonucleotides, opening up opportunities for functional studies of the isoforms as well as for therapeutics for autoimmune diseases. This study provides insight into CD46 alternative splicing regulation with implications for its function in the immune system and for genetic disease.
在此,我们对人类CD46的可变剪接调控进行了详细分析,该调控产生了具有不同功能的不同异构体。CD46是一种普遍存在的膜蛋白,可保护宿主细胞免受补体攻击,并在免疫、自噬和细胞黏附中发挥其他作用。CD46缺陷会导致自身免疫性疾病,并且该蛋白还与病原体感染和癌症有关。在本研究之前,尽管CD46可变剪接过程的失调与自身免疫性疾病相关,但其机制仍未得到探索。我们证明,编码细胞外结构域的CD46盒式外显子7和8的5'剪接位点是由与U1小核RNA碱基配对的非经典机制定义的。接下来,我们对CD46盒式外显子13的调控进行了表征,其包含或跳过会产生具有不同功能的不同细胞质尾巴。使用剪接微型基因,我们鉴定了多个外显子和内含子剪接增强子和沉默子,它们通过PTBP1和TIAL1等反式作用剪接因子调节外显子13的包含。有趣的是,一种常见的剪接激活剂,如SRSF1,似乎会抑制CD46外显子13的包含。我们还报告说,CD46 mRNA异构体的表达进一步受到无义介导的mRNA降解和转录速度的调控。最后,我们使用反义寡核苷酸成功地操纵了CD46外显子13的包含,为异构体的功能研究以及自身免疫性疾病的治疗开辟了机会。这项研究为CD46可变剪接调控提供了见解,对其在免疫系统中的功能和遗传疾病具有重要意义。